GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (ASX:NAN) » Definitions » 3-Year EBITDA Growth Rate

Nanosonics (ASX:NAN) 3-Year EBITDA Growth Rate

: 20.40% (As of Dec. 2023)
View and export this data going back to 2007. Start your Free Trial

Nanosonics's EBITDA per Share for the six months ended in Dec. 2023 was A$0.03.

During the past 12 months, Nanosonics's average EBITDA Per Share Growth Rate was 35.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 20.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Nanosonics was 108.00% per year. The lowest was -25.50% per year. And the median was 20.10% per year.

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Nanosonics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanosonics 3-Year EBITDA Growth Rate Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Nanosonics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Nanosonics's 3-Year EBITDA Growth Rate falls into.


Nanosonics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Nanosonics  (ASX:NAN) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Nanosonics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Nanosonics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanosonics (ASX:NAN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (ASX:NAN) » Definitions » 3-Year EBITDA Growth Rate
Comparable Companies
ASX:TRJ ASX:SDI ASX:AHC ASX:OSX ASX:ANN ISRG XPAR:EL BDX TSE:7741 XSWX:ALC OCSE:COLO B RMD WST XPAR:DIM TSE:4543 XSWX:STMN BAX COO HOLX TSE:7733
Traded in Other Exchanges
NNCSF:USA OQS:Germany
Address
7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113
Website
https://www.nanosonics.com.au
Nanosonics is a single-product firm and its trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low temperature sonically activated hydrogen peroxide mist that is suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection across patients. Nanosonics' revenue is made up of capital sales of trophon units, ongoing consumables sales, and service revenue. At June 2022, there were 29,850 trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, roughly 44% in the U.S. to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in Asia-Pacific.

Nanosonics (ASX:NAN) Headlines